Cytoplasmic Activated PD-1 CAR T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cytoplasmic Activated PD-1 CAR T Cells, covering 2018-05-30 to 2018-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma [Phase 1]